175 INNOVATION BOULEVARD, WILMINGTON, DE
Market cap: $115.3M (2/10/2026)
Price: $2.09
Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
Investor Presentation
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Announces Exclusive Option Agreement to Advance Mutant Selective JAK2V617F JH2 Inhibitors
Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
Other Events
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Material disclosure
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Amended Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Free Writing Prospectus
Correspondence
Submission Upload
S-1MEF